- Home
- XYF vs PHAR Comparison
XYF vs PHAR Comparison
Compare XYF & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XYF
- PHAR
- Stock Information
- Founded
- XYF 2014
- PHAR 1988
- Country
- XYF China
- PHAR Netherlands
- Employees
- XYF N/A
- PHAR N/A
- Industry
- XYF Finance: Consumer Services
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- XYF Finance
- PHAR Health Care
- Exchange
- XYF Nasdaq
- PHAR Nasdaq
- Market Cap
- XYF 582.9M
- PHAR 587.5M
- IPO Year
- XYF 2018
- PHAR N/A
- Fundamental
- Price
- XYF $13.41
- PHAR $10.01
- Analyst Decision
- XYF
- PHAR Strong Buy
- Analyst Count
- XYF 0
- PHAR 3
- Target Price
- XYF N/A
- PHAR $30.00
- AVG Volume (30 Days)
- XYF 130.5K
- PHAR 3.0K
- Earning Date
- XYF 05-29-2025
- PHAR 05-08-2025
- Dividend Yield
- XYF 2.68%
- PHAR N/A
- EPS Growth
- XYF 28.68
- PHAR N/A
- EPS
- XYF 4.32
- PHAR N/A
- Revenue
- XYF $804,452,842.00
- PHAR $23,805,200,000.00
- Revenue This Year
- XYF N/A
- PHAR $12.39
- Revenue Next Year
- XYF N/A
- PHAR $9.84
- P/E Ratio
- XYF $2.98
- PHAR N/A
- Revenue Growth
- XYF 21.95
- PHAR 9113.93
- 52 Week Low
- XYF $3.68
- PHAR $6.65
- 52 Week High
- XYF $17.70
- PHAR $11.07
- Technical
- Relative Strength Index (RSI)
- XYF 52.84
- PHAR 71.58
- Support Level
- XYF $12.50
- PHAR $8.60
- Resistance Level
- XYF $14.45
- PHAR $9.40
- Average True Range (ATR)
- XYF 1.00
- PHAR 0.34
- MACD
- XYF -0.02
- PHAR 0.15
- Stochastic Oscillator
- XYF 71.80
- PHAR 87.89
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.